Oral Ibuprofen doses above 400 mg do not provide additional pain control in adults

Published On 2019-08-18 14:40 GMT   |   Update On 2019-08-18 14:40 GMT

Oral ibuprofen administered at dosage 800 mg is no better than 400 mg for short-term pain relief in adults, revealed a randomized control trial published Annals of Emergency Medicine.


Ibuprofen is a commonly used analgesic given to people who are presented at the Emergency Department (ED) for short term pain relief. Large doses of ibuprofen are often used for emergency department (ED) patients, despite evidence that doses above 400 mg increase rates of side effects without improving pain control. When acute pain is managed, however, the analgesic ceiling dose of ibuprofen at 400 mg is sufficient to reduce pain and inflammation.


Read More: High-Dose Ibuprofen best medical option for PDA closure in preterm infants


To compare the efficacy of smaller dose of the drug with bigger doses a team of scientists led by Sergey Motov of Department of Emergency Medicine, Maimonides Medical Center, Brooklyn, NY conducted a randomized control including 225 subjects presented at the emergency department with acute painful conditions.


Primary outcome included a difference in pain scores between the 3 groups at 60 minutes.


Key observations




  • The difference in mean pain scores at 60 minutes between the 400- and 600-mg groups was –0.14 .

  • between the 400- and 800-mg groups, 0.14

  • between the 600- and 800-mg groups, 0.00.

  • Reductions in pain scores from baseline to 60 minutes were similar for all subjects in each of the 3 groups. No adverse events occurred in any group.


Based on the results of the study the authors concluded that






Oral ibuprofen administered at doses of 400, 600, and 800 mg has similar analgesic efficacy for short-term pain relief in adult patients presenting to the ED with acute pain.


"We firmly believe that with the proper patient and provider education supported by the evidence, the myth of better pain relief with “prescription-only” dosages will be debunked, wrote the authors."


Read more: NSAID’s use in osteoarthritis tied to increased risk of CVD, finds study


For reference, click on the link


DOI: https://doi.org/10.1016/j.annemergmed.2019.05.037





Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News